div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=documentn19-908s022-zolpidem-clinical-bpca-clinical-bpca-zolpidem-was-unacceptably-highhtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: N19-908S022 Zolpidem Clinical BPCA Clinical BPCA · zolpidem was unacceptably high 74% in comparison with the incidence in patients treated with placebo 0% for comparison in loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader030fdocumentsinreader030viewer20220411155f262cb8eac7f6171a65bbd9html5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=documentn19-908s022-zolpidem-clinical-bpca-clinical-bpca-zolpidem-was-unacceptably-highhtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: N19-908S022 Zolpidem Clinical BPCA Clinical BPCA · zolpidem was unacceptably high 74% in comparison with the incidence in patients treated with placebo 0% for comparison in loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader030fdocumentsinreader030viewer20220411155f262cb8eac7f6171a65bbd9html5thumbnails2jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imageimg data-url=documentn19-908s022-zolpidem-clinical-bpca-clinical-bpca-zolpidem-was-unacceptably-highhtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: N19-908S022 Zolpidem Clinical BPCA Clinical BPCA · zolpidem was unacceptably high 74% in comparison with the incidence in patients treated with placebo 0% for comparison in loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII=...